Luoxin Aurovitas

Luoxin Aurovitas is a strategic joint venture between Shandong Luoxin Pharmaceutical Group and the Indian multinational Aurobindo Pharma. Based in Chengdu, China, the company specializes in the development, manufacturing, and commercialization of high-quality generic medications and complex formulations. Its primary therapeutic focus includes respiratory health, anti-infectives, and gastrointestinal disorders, with a notable emphasis on inhalation drug delivery systems. By combining Aurobindo's extensive global R&D and product portfolio with Luoxin's robust domestic distribution network, the venture aims to provide affordable and advanced healthcare solutions to the Chinese market. The company operates state-of-the-art facilities that adhere to international GMP standards to ensure the delivery of high-barrier therapeutic products.